Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    EyeGate Pharmaceuticals I...

    NASDAQ: EYEG · Real-Time Price · USD
    35.47
    0.41 (1.17%)
    At close: Jul 03, 2025, 1:04 PM

    EyeGate Pharmaceuticals Statistics

    Share Statistics

    EyeGate Pharmaceuticals has 753.13K shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 753.13K

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 8.45%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 68

    FTD / Avg. Volume

    n/a
    		 7.2%

    Short Selling Information

    The latest short interest is 1.31K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.31K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 3.8

    Valuation Ratios

    The PE ratio is 17.54 and the forward PE ratio is null. EyeGate Pharmaceuticals's PEG ratio is 0.

    PE Ratio

    n/a
    		 17.54

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 8.46

    Forward PS

    n/a
    		 47

    PB Ratio

    n/a
    		 5.26

    P/FCF Ratio

    n/a
    		 15.84

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    EyeGate Pharmaceuticals has an Enterprise Value (EV) of 131.77M.

    EV / Sales

    n/a
    		 8.23

    EV / EBITDA

    n/a
    		 0

    EV / EBIT

    n/a
    		 15.4

    EV / FCF

    n/a
    		 15.41

    Financial Position

    The company has a current ratio of 4.94, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 4.94

    Quick Ratio

    n/a
    		 4.94

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 0.01

    Interest Coverage

    n/a
    		 -122.89

    Financial Efficiency

    Return on Equity is 29.99% and Return on Invested Capital is 11.79%.

    Return on Equity

    n/a
    		 29.99%

    Return on Assets

    n/a
    		 21.17%

    Return on Invested Capital

    n/a
    		 11.79%

    Revenue Per Employee

    n/a
    		 $1,144,285.71

    Profits Per Employee

    n/a
    		 $551,767.36

    Employee Count

    n/a
    		 14

    Asset Turnover

    n/a
    		 0.44

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -2.07M

    Effective Tax Rate

    n/a
    		 -36.49%

    Stock Price Statistics

    The stock price has increased by -1.38% in the last 52 weeks. The beta is 0.23, so EyeGate Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.23

    52-Week Price Change

    n/a
    		 -1.38%

    50-Day Moving Average

    n/a
    		 35.05

    200-Day Moving Average

    n/a
    		 35.53

    Relative Strength Index (RSI)

    n/a
    		 61.35

    Average Volume (20 Days)

    n/a
    		 944

    Income Statement

    In the last 12 months, EyeGate Pharmaceuticals had revenue of 16.02M and earned 7.72M in profits. Earnings per share was 1.99.

    Revenue

    n/a
    		 16.02M

    Gross Profit

    n/a
    		 16.02M

    Operating Income

    n/a
    		 2.64M

    Net Income

    n/a
    		 7.72M

    EBITDA

    n/a
    		 n/a

    EBIT

    n/a
    		 5.64M

    Earnings Per Share (EPS)

    n/a
    		 1.99
    Full Income Statement

    Balance Sheet

    The company has 3.79M in cash and 57.17K in debt, giving a net cash position of 3.74M.

    Cash & Cash Equivalents

    n/a
    		 3.79M

    Total Debt

    n/a
    		 57.17K

    Net Cash

    n/a
    		 3.74M

    Retained Earnings

    n/a
    		 -143.38M

    Total Assets

    n/a
    		 34.02M

    Working Capital

    n/a
    		 21.83M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 8.56M and capital expenditures -6.26K, giving a free cash flow of 8.55M.

    Operating Cash Flow

    n/a
    		 8.56M

    Capital Expenditures

    n/a
    		 -6.26K

    Free Cash Flow

    n/a
    		 8.55M

    FCF Per Share

    n/a
    		 2.21
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of 16.45% and 48.22%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 16.45%

    Pretax Margin

    n/a
    		 35.33%

    Profit Margin

    n/a
    		 48.22%

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 16.45%

    FCF Margin

    n/a
    		 53.39%

    Dividends & Yields

    EYEG pays an annual dividend of $2.26, which amounts to a dividend yield of 6.02%.

    Dividend Per Share

    n/a
    		 $2.26

    Dividend Yield

    n/a
    		 6.02%

    Dividend Growth (YoY)

    n/a
    		 -4.54%

    Payout Ratio

    n/a
    		 -127.65%

    Earnings Yield

    n/a
    		 5.7%

    FCF Yield

    n/a
    		 6.31%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for EYEG.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 17.28

    Graham Upside

    n/a
    		 -50.5%

    Stock Splits

    The last stock split was on Aug 30, 2019. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Aug 30, 2019

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -2.66

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist